Optical Q™  Fluorescence Immunoassay Analyzer

Information

Optical Q™ is a cutting edge in-vitro diagnostics (IVD) fluorescence immunoassay (FIA) point of care (POCT) analyzer that accurately measures the concentration of analytes contained in blood, serum, plasma, and other samples. Results are generated within a prompt 15 minute time frame with CV's ranging from 5%~10%. In contrast to standard FIA analyzers that use gold nano-particles, Optical Q utilizes highly sensitive fluorescent material and incorporates world class lens technology to not only test for the presence of a disease but also accurately quantify the concentration - or severity - of the disease. In addition, Optical Q features a wide variety of diagnostic marker - many of which are developed in-house - that covers health categories including but not limited to inflammation, infection, diabetes, vitamin D deficiency, thyroids, and more. Our capacity to develop our device and antibodies in-house enables optimized performance against competitors. Optical Q is truly a rapid one-stop diagnostic solution. --------------------------------------------------------------------------- Optical Q™ features 25 parameters / reagents as seen below: Inflammation: CRP, PCT Tumor: AFP, CEA, PSA Hormone: Beta-hCG, LH, FSH, PRL, Cortisol, Testosterone, Progesterone Thyroid: TSH, Total T3, Free T3, Total T4, Free T4 Cardiac: Myoglobin, CK-MB, D-Dimer, NT-proBNP Diabetes: HbA1c Others: Ferritin COVID-19: Neutralizing antibody (nAb), Antigen (Ag)
0ptiBio Co., Ltd.OptiBio is a South Korean in-vitro diagnostics (IVD) company focused in researching, developing, and manufacturing cutting edge fluorescence immunoassay (FIA) solutions. In 2020, OptiBio was selected by a research fund sponsored by the Bill & Melinda Gates foundation for its unique and dedicated approach to immunoassay. OptiBio's competitive advantage stems from its strong foundation of experts, each specialized in fields crucial for product development. Our R&D is divided into 3 different teams of scientists and engineers dedicated to the independent development of diagnostic markers, test kits, and analyzers.  Our fundamental approach to in-house specialization allows OptiBio to constantly improve our product performance, customize our solutions based on client feedback, develop new test parameters, and respond to changing market needs. Shortly following the outbreak of Covid-19, for example, OptiBio quicky developed, without any outsourcing, the Optical Q SARS-CoV-2 neutralizing antibody (nAb) test kit and Rapid Q SARS-CoV-2 Antigen (Ag) rapid test kit.  OptiBio will continue to create, improve, and innovate world class diagnostic solutions in the field of fluorescence immunoassay and point-of-care testing (POCT). Through this, we aim to ultimately transform medical diagnosis into a universally available right.  --------------------------------------------------------------------------- Optical Q, OptiBio's proprietary fluorescence immunoassay analyzer brand, currently features 25 test parameters. Please see below for details:  Inflammation: CRP, PCT                                                                                            Tumor: AFP, CEA, PSA                                                                                             Hormone: Beta-hCG, LH, FSH, Prolactin, Cortisol, Testosterone, Progesterone Thyroid: TSH, Total T3, Free T3, Total T4, Free T4                                               Cardiac: Myoglobin, CK-MB, D-dimer, NT-proBNP                                            Diabetes: HbA1c                                                                                                      Others: Ferritin                                                                                                         COVID-19: Neutralizaing antibody (nAb), Antigen (Ag)